A coagulation and fibrinolytic study in children with nephrotic syndrome: Evaluation of hypercoagulability by measuring plasmin-α2 plasmin inhibitor complex and FDP D-dimer

Japanese Journal of Nephrology

Volumn 39, Issue 2, 1997, Pages 144-149

  Oikawa, Tsuyoshi ^a   Muramatsu, Yasuo ^a   Akashi, Shunji ^a   Usui, Nobuo ^b  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FDP D dimer; Hypercoagulability; Nephrotic syndrome; Plasmin 2 plasmin inhibitor complex

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTIPLASMIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PLASMIN; PLASMIN PLASMIN INHIBITOR COMPLEX; PLASMIN-PLASMIN INHIBITOR COMPLEX;

ADOLESCENT; ARTICLE; BLOOD; BLOOD CLOTTING; CHILD; FEMALE; FIBRINOLYSIS; HUMAN; MALE; NEPHROTIC SYNDROME; PRESCHOOL CHILD;

ADOLESCENT; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; BLOOD COAGULATION; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MALE; NEPHROTIC SYNDROME; PLASMIN;

EID: 0031090415     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mehls O, Andrassy K, Koderrisch J, Herzog U, Ritz E. Homeostasis and thromboembolism in chidren with nephrotic syndrome: Differences from adults. J Pediatr 1987; 110: 862-867.
2. Egli F, Elminger P, Stalder G. Thromboembolism in nephrotic syndrome. Pediatr Res 1974; 8: 903.
3. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28: 429-439.
4. Hoyer PF, Gonda M, Barthels M, Krohn P, Prodehl J. Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Pediatr Scand 1986; 75: 804-810.
5. Kanfer A. Coagulation factors in nephrotic syndrome. Am J Nephrol 1990; 10 (suppl 1): 63-68.
6. Kauffman RH, Veltkamp JJ, Van Tiburg NH, Van Es LA. Acquired anti-thrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 1976; 60: 1048-1054.
7. Lau SO, Tkachuk JY, Hasegawa DK, Edson JR. Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr 1980; 96: 390-392.
8. Vaziri ND, Alkhani S, Patel B, Nguyen Q, Barton CH, Gonzales EV. Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome. Nephron 1988; 49: 20-23.
9. Boneu B, Bouissou F, Abbal M, Sie P, Caranobe C, Barthe P. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome. Thromb Haemostasis 1981; 45: 623-625.
10. Du XH, Glass Greenwalt P, Kant KS, Allen CM, Hayes S, Pollak VE. Nephrotic syndrome with renal vein thrombosis: Pathogenic importance of a plasma inhibitor (alpha 2 anti-plasmin). Clin Nephrol 1985; 24: 186-191.
11. McGinley E, Lowe GDO, Boulton-Jones M, Forbes CD, Prentice CRM. Blood viscosity and haemostasis in the nephrotic syndrome. Thromb Haemostas 1983; 49: 155-157.
12. Machleidt C, Mettang T, Atarz E, Weber J, Risler T, Kuhlmann U. Multifactorial genesis of enhanced platelet aggregatability in patients with nephrotic syndrome. Kidney Int 1989; 36: 1119-1124.
13. Vaziri ND, Gonzales EC, Barton CH. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 1994; 124: 118- 124.
14. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Barsotti G. In vivo measurement of fibrin formation and degradation in nephrotic syndrome. Int J Clin Lab Res 1994; 24: 113-116.
15. De Mattia D, Penza R, Giordano P, Di Bitonto G, Altomare M, Del Vecchio GC, Shettini F. Thrombotic risks in children with nephrotic syndrome. Haemostasis 1991; 21: 300-304.
16. Abshire TC, Fink LK, Christian J, Hathaway WE. The prolonged thrombin time of nephrotic syndrome. J Pediatr Hematol Oncol 1995; 17: 156-162.
17. Hughes GRV, Asherson RA, Khamashta MA. Antiphospholipid syndrome: linking many specialities. Ann Rheum Dis 1989; 48: 355-356.